华绿生物
(300970)
| 流通市值：12.98亿 | | | 总市值：16.83亿 |
| 流通股本：9272.94万 | | | 总股本：1.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 270,596,190.27 | 1,032,111,560.17 | 735,466,949.07 | 462,529,323.08 |
| 营业收入 | 270,596,190.27 | 1,032,111,560.17 | 735,466,949.07 | 462,529,323.08 |
| 二、营业总成本 | 271,307,730.48 | 1,072,414,292.17 | 772,482,385.4 | 508,635,192.56 |
| 营业成本 | 250,582,924.99 | 970,609,145.98 | 698,625,329.08 | 460,811,781.49 |
| 税金及附加 | 153,128.04 | 757,423.61 | 523,982.5 | 350,838.08 |
| 销售费用 | 2,233,467.51 | 10,829,040.29 | 8,024,933.44 | 5,313,301.36 |
| 管理费用 | 14,602,620.5 | 67,674,468.18 | 51,480,419 | 35,168,069.34 |
| 研发费用 | 1,880,483.78 | 14,605,198.13 | 11,772,434.56 | 6,517,335.67 |
| 财务费用 | 1,855,105.66 | 7,939,015.98 | 2,055,286.82 | 473,866.62 |
| 其中:利息费用 | - | 11,184,462.3 | 5,324,550.55 | 3,418,792.75 |
| 其中:利息收入 | - | 3,282,699.92 | -3,300,864.44 | 2,970,184.86 |
| 加:投资收益 | - | 86,571.69 | 86,571.69 | 86,571.69 |
| 资产处置收益 | -109,668.96 | -1,483,161.95 | -178,857.96 | -121,493.42 |
| 资产减值损失(新) | -9,270.98 | -11,948,029.48 | -4,196,358.12 | -4,193,982.54 |
| 信用减值损失(新) | - | -1,905,786.2 | -848,691.74 | -844,730.42 |
| 其他收益 | 2,914,374.55 | 11,466,924.82 | 8,290,090.16 | 5,875,645.68 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,083,894.4 | -44,086,213.12 | -33,862,682.3 | -45,303,858.49 |
| 加:营业外收入 | 63,241.76 | 541,714.77 | 430,269.9 | 326,075.54 |
| 减:营业外支出 | 182,850.79 | 733,792.69 | 487,047.37 | 329,835.14 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,964,285.37 | -44,278,291.04 | -33,919,459.77 | -45,307,618.09 |
| 减:所得税费用 | - | 145,140.46 | 115,369.48 | 77.88 |
| 六、净利润 | 1,964,285.37 | -44,423,431.5 | -34,034,829.25 | -45,307,695.97 |
| 持续经营净利润 | - | -44,423,431.5 | - | -45,307,695.97 |
| 归属于母公司股东的净利润 | 1,544,654.24 | -47,565,525.06 | -35,089,857.04 | -44,824,475.05 |
| 少数股东损益 | 419,631.13 | 3,142,093.56 | 1,055,027.79 | -483,220.92 |
| (一)基本每股收益 | 0.01 | -0.41 | -0.3 | -0.38 |
| (二)稀释每股收益 | 0.01 | -0.41 | -0.3 | -0.38 |
| 九、综合收益总额 | 1,964,285.37 | -44,423,431.5 | -34,034,829.25 | -45,307,695.97 |
| 归属于母公司股东的综合收益总额 | 1,544,654.24 | -47,565,525.06 | -35,089,857.04 | -44,824,475.05 |
| 归属于少数股东的综合收益总额 | 419,631.13 | 3,142,093.56 | 1,055,027.79 | -483,220.92 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |